ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 684459 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 684459; 2) Community: the network communities that were significantly associated with the response to NSC 684459; 3) Molecule: the relationships between components within communities and NSC 684459; 4) MDR: the compounds that were significantly associated with the NSC 684459.

NSC Compound Enrichment Correlation
NSC 756134 GSK1023156A 0.0181211508101519 -0.25977366
NSC 75890 1,9-Pyrazoloanthrone 0.0181211508101519 -0.019750118
NSC 251667 ERIOFLORIN ACETATE 0.0187206825450445 -0.30019602
NSC 619042 Cyclohexanone, 2,6-bis[(dimethylamino)methyl]-, dihydrochloride 0.0187206825450445 -0.22936272
NSC 669145 2-Butenoic acid, 2-methyl-, 2,3,3a,4,5,6,7,11a-octahydro- 6,10-dimethyl-3-methylene-2,7-dioxo-6,9-epoxycyclodeca[b]furan-4-yl ester, [3aR-[3aR*,4S*(Z),6R*,10Z,11aR*]]- 0.0187206825450445 -0.33545287
NSC 675006 Null 0.0187206825450445 -0.50861189
NSC 685470 Null 0.0187206825450445 -0.51100292
NSC 688816 Null 0.0187206825450445 0.50867798
NSC 104801 Cytembena 0.0208632511155816 -0.30494288
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.0208632511155816 -0.26144332
Total:86  Current:33    [First] [Prev] [Next] [Last]